Key result
The addition of magnesium to cardioplegic solutions did not significantly affect TROP I and CKMB mass levels in children undergoing surgical correction of congenital heart malformations.
Why the study?
Does the addition of magnesium to cardioplegic solutions reduce Troponin I and CKMB mass levels in children undergoing surgical correction of congenital heart malformations?
Does the addition of magnesium to cardioplegic solutions reduce Troponin I and CKMB mass levels in children undergoing surgical correction of congenital heart malformations?
Answers are grounded in this paper and cite their sources.
The addition of magnesium to cardioplegic solutions did not significantly alter postoperative Troponin I and CKMB mass levels in children undergoing congenital heart surgery.
OBJECTIVE: To analyze the behavior of troponin (TROP I) and CKMB mass (CKMBm) in regards to the addition of magnesium in cardioplegic solutions; and also the influence of per-operative factors. METHOD: A total of 28 children with ages ranging from 3 to 108 months were studied. The mean weight was 11.8 kg. Eighteen were male. The patients were divided into two groups. Sixteen children in group I (GI) and 12 in group II (GII). The patients in GI received cold blood cardioplegic solution with magnesium (12 mEq/L) and potassium chloride (20 mEq/L) at 20 mL/kg. The patients in GII received the same solution without magnesium. Six blood samples were collected for serum analysis of the concentration of TROP I and CKMBm. The blood samples were collected before clamping the aorta and at 1, 6, 24, 48 and 72 hours after aorta clamping termination. RESULTS: There were no statistical differences in the TROP I and CKMBm levels between the two groups. Among the per-operative factors cyanosis influenced the TROP I and CKMBm levels. Additionally, the aorta clamping time influenced the TROP I levels. CONCLUSIONS: The addition of magnesium in the cardioplegic solution was not associated with different levels of TROP I and CKMBm. Cyanosis and aorta clamping time interfered with peak TROP I levels.
No takes yet. Share an insight, caveat, or question.
Salerno et al. (2003) studied Congenital heart malformations (n=28). Cardioplegic solution with magnesium vs. Cardioplegic solution without magnesium was evaluated on TROP I and CKMB mass levels. The addition of magnesium to cardioplegic solutions did not significantly affect TROP I and CKMB mass levels in children undergoing surgical correction of congenital heart malformations.
Synapse has enriched 10 related papers. Consider them for comparative context: